She was unconscious with a Glascow Coma Score 5/15. She had shallow breaths, systolic BP 60 mmHg, heart rate 80/min and cool peripheries. The history was of self-poisoning but the drug or drugs and time of ingestion were unknown. Her general practitioner had prescribed her seven doxepin 75 mg tablets and fourteen temazepam 10 mg tablets two days before for acute depression. She was not taking any other medication.
Oxygen by mask and intravenous fluids were commenced. Her heart rate fell quickly to 30/minute and atropine 0.6 mg, plus twn doses of adrenaline 250 micrograms increased it only to 40/minute. Intubation then became necessary. By 1600 hours, two litres of 0.9% saline and 500 ml of Haemaccel had been given, and this improved her peripheral perfusion. She had a systolic BP 70 mmHg and pulse 60/min with nodal rhythm. Two doses of adrenaline 1 mg were given and a dopamine infusion at 1000 ~g/min (60 mg/hr) was started via a central venous line. Arterial blood gas analysis on 100% oxygen was pH 7.13, PaC02 2.5 kPa, P a o 2 13.9 kPa, bicarbonate 6 mmolll. Sodium bicarbonate 100 mmol was given and activated charcoal instilled nasogastrically.
At this stage a beta-blocker overdose was suspected. The patient was therefore given incremental doses of isoprenaline to a total of 200 Ilg, followed by glucagon 2 mg (our total Emergency Department supply), dobutamine 250 mg over ten minutes, calcium 10 mmol, bicarbonate and finally three doses of adrenaline to a total of 7 mg. The dopamine infusion was continued throughout. In spite of this her BP remained around 40 mmHg systolic, her pulse 70-85/min in nodal rhythm, and her peripheries warm with a slow capillary refill.
A cardiologist was called and ventricular pacing was not thought necessary as her heart rate was 70-85/min. Serum electrolyte results from 1615 hours were sodium 138 mmol/l, potassium 5.3 mmolll, glucose 19.3 mmol/l, urea 3.1 mmolll, creatinine .144 mmolll and ionised calcium 1.13 mmolll.
She was transferred to the Intensive Care Unit at 1 700 hours. Three 5 mg adrenaline boluses at five minute intervals did not produce an improvement. After discussion a 20 mg adrenaline bolus was given at 1730 hours. Her BP rose from 40 to 100 mmHg systolic and heart rate increased to 110/ minute but still in a nodal rhythm. An infusion of adrenline was started at 1333 Ilglmin (80 mglhr) and at 1800 hours her BP was 140 mmHg, heart rate 100/min, with peripheries better perfused. The dopamine infusion was then stopped. The adrenaline infusion was decreased as her circulation improved and by 2200 hours was only 33 Ilglmin (2 mglhr). At 2300 hours she was awake and able to be extubated. A urinary catheter was inserted at 2000 hours and she maintained a good urine output overnight. Her creatinine increased to 0.188 mmol/l at 2100 hours but had fallen to 0.13 mmol/l at 0730 hours. The serum potassium was 4.4 mmol/l at 0730 hours after receiving a total of 135 mmol potassium chloride overnight. Her serum glucose rose to 22 mmol/l during the adrenaline infusion and fell to 9.2 mmolll by 0730 hours without exogenous insulin. After gradual improvement she was weaned off the adrenaline at 1300 hours, that day, with a BP of 100/55 mmHg and heart rate of 80/minute.
She admitted later to taking approximately 56 to 70 X 100 mg labetalol tablets, 20-30 mg prednisone and four to six azathioprin tablets (her husband's renal medication), the doxepin and temazepam prescribed by her general practitioner and ten to twenty anginine tablets (dispensed twelve months previously). The drugs were all taken on the evening of the day before admission.
Twenty-four hours after admission she was transferred from ICU to a general medical ward and the following day was discharged home after psychiatric consultation. Neurological examination was normal at discharge and one month follow up. During her twenty-four hour Intensive Care stay she received a total of 174 mg of adrenaline.
DISCUSSION
The management of this patient was difficult and confusing. Her failure to make any response to large doses of potent drugs left us with few, if any, options. The initial fluid load continued as her peripheries were warming up but was stopped when her JVP rose. Unfortunately central venous pressure was not measured. Between 161 5 and 1700 hours large doses of several drugs were used; isoprenaline 200 Ilg in an attempt to speed up her heart rate, dobutamine 250 mg to counter any betaantagonist depression of contractility, adrenaline 7 mg for inotropy and vasoconstriction, and glucagon 2 mg for its known effect in beta-blocker poisoning. Despite this no improvement was seen. After transferring to ICU, pulmonary artery catherisation was not undertaken as the problem was an inability to produce any effect from any drug, rather than diagnostic uncertainty. Once resuscitated, her condition became stable and rapidly improved.
Labetal01 is a competitive alpha-and betaadrenergic receptor blocking agent. It has equal potency at beta]-and betar receptors, and the ratio of alpha-:beta-receptor blocking potency is 1:3 to 1:7.7 The lack of effect of adrenaline at 1, 2 and 5 mg doses is consistent with a competitive blockade, which needs an exponentially higher dose of agonist to overcome it. Adrenaline has not been reported as being used to overcome adverse haemodynamic effects of labetalol but glucagon, dopamine and isoprenaline have. 5 ,6,8 As adrenaline is an alpha-and beta-agonist it would appear the most logical agent to treat labetalol effects. Adrenaline has been used in pure beta-blocker overdose and has been reviewed as being effective in increasing the heart rate in 67% and BP in 50% of patients;9 however, doses of the magnitude used in this case were not given. The unopposed alpha actions of adrenaline when treating beta-blocker overdose do not appear to have been a problem. 9 Glucagon has been successful in unresponsive betablocker overdoses, using 10 mg boluses with 3-5 mglhr infusions.], 9,] O It was used in one labetalol overdose without success 6 and unfortunately we only had 2 mg. It is unlikely that the ten to twenty anginine tablets were causing any effects at the time of her admission as the tablets have low efficacy orally, a short half-life and had passed their expiry date.
The clinical presentation of this case is similar to pure beta-blocker overdose with bradycardia and hypotension. During the initial stages with a systolic blood pressure of 40 mmHg, the patient at all times had peripheral circulation with limbs that were slightly warm with a slow capillary refill. This fact encouraged us to continue the resuscitation and try progressively larger doses of adrenaline. The good cerebral outcome after at least two hours of profound hypotension is consistent with other reports of beta-blocker overdose. 3 ,4,9 Similarly, renal failure does not seem to occur with the exception of one report of a patient with a labetalol overdose who developed acute oliguric renal failure after only moderate hypotension. 5 In the present case the patient maintained a good urine output once resuscitated although her creatinine transiently rose to 0.188 mmolll six hours after admission. The patient did not have any apparent seizures which are a feature of propranolol overdose. 9 The treatment of patients who have overdosed with unknown drugs can be difficult. In a similar case, a patient with a history of an overdose of phenytoin and phenobarbitone presented with coma, hypotension and bradycardia. She received boluses of adrenaline to a total of 4 mg plus an infusion at 66 Ilg/min and was subsequently found to have taken an overdose of metoprolol. 2 It is important to remember the exponential relationship between agonists and antagonists at receptors. If patients with beta-blocker overdose arrive at hospital alive, then the prognosis with appropriate therapy appears good. 9 , IO 
